Facts
as of Nov 19, 2026
CancerIQ helps clinicians identify patients who qualify for screening and diagnostic tests, engage them directly, and guide them to completion — from prevention through survivorship.
It is hiring: 1 open role, 0 of them posted in the last 30 days.
- Legal name
- Cancer IQ Inc.
- Headquarters
- Chicago, United States
- Employees
- 27US Form 5500 (plan participants) · Dec 2025 · -21% in a year
- Open roles
- 1Alion job postings
- Register numbers
- EIN 461976149
As of Nov 19, 2026, Alion lists 1 open role at CancerIQ. CancerIQ is headquartered in Chicago, United States. It has raised $15.6M in 2 funding rounds. The latest round is Venture - Series Unknown of $14M, announced in 2022.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Cancer IQ Inc.
Not checked
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring slowly: few roles were posted lately.
Product is the largest family, 100 of open roles.
0%Remote roles0 of 1
1Hiring offices
Can they hire you from United States?by your location
Likely
2 open roles are in your country: you apply locally, no move needed.
United States2On site
Remote, from elsewhere0Rare
No posting offers visa sponsorship. Remote roles: 0.
Alion signals0-100
Demand8
Pay5
Your chance43
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time
Sep 14This week
Open roles a week: 1 then, 1 now
Where the openings areshare of open roles · trend
Newest roles
Senior Product Manager≈ $115k – $213k per year (Estimated) · In office · Full-Time · 10+ years exp · Bachelor's Degree · Chicago
Degree asked
Bachelor's Degree 100%
1 postings state a degree.
Benefits named in postingsshare of open roles
Professional development1100%
Gym membership1100%
Contract type
Full-Time 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
ChicagoBusiest site
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$15.6MTotal raised
Debt FinancingLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2023$4.3M1 record
2022$14M1 record
2020$1.6M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers
Money
CancerIQ has $19.9M paid in by investors, lenders and donors.
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Loan or credit
Nov 2023 · Debt financing
$4.3MPaid
Equity raised
Mar 2022 · Venture round
$14MPaid
Equity raised
Feb 2020 · Venture round
$1.6MPaid
Taxes
No public tax figures for this company or its entities.
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Owners & entities
CancerIQ operates through 1 legal entities in 1 countries.
Named investors, no share stated2
Amgen VenturesMerck Global Health Innovation Fund
Legal entities1 in 1 countries
Cancer IQ Inc.
operator · US EIN 461976149
US
Holders and shares as each register or filing states them.
Public record
CancerIQ: 1 federal court cases.
US federal cases naming it as a party
Mar 2021 – Mar 2021 · 1 as defendant · 1 closed
Most common: 830 Patent 1
1
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
Milestones
2025
Team shrank to 27 was 34 · US Form 5500 (plan participants)
Each milestone is dated by its source: registers, filings, the press
Newsroom
top 6%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once